Assessing Time of Onset for Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Dermatomyositis

JAMA Dermatol. 2024 May 1;160(5):575-577. doi: 10.1001/jamadermatol.2024.0507.
No abstract available

Plain language summary

This cohort study seeks to describe the time interval between interstitial lung disease and anti–melanoma differentiation-associated gene 5 antibody-positive dermatomyositis diagnoses.

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Autoantibodies* / blood
  • Autoantibodies* / immunology
  • Dermatomyositis* / blood
  • Dermatomyositis* / diagnosis
  • Dermatomyositis* / immunology
  • Female
  • Humans
  • Interferon-Induced Helicase, IFIH1* / immunology
  • Lung Diseases, Interstitial* / diagnosis
  • Lung Diseases, Interstitial* / immunology
  • Male
  • Middle Aged